$GMED Income Statement | Understand Stock

$GMED

$80.90 -$0.93 (1.14%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net sales
Cost of Sales and Operating expenses:
Cost of sales (exclusive of amortization of intangibles)
Gross profit
Research and development
Selling, general and administrative
Provision for litigation, net
Amortization of intangibles
Acquisition-related costs
Total operating expenses
Restructuring costs
Operating income/(loss)
Other income/(expense), net:
Interest income/(expense), net
Foreign currency transaction gain/(loss)
Other income (expense)
Bargain purchase gain
Other income/(expense)
Total other income/(expense), net
Income/(loss) before income taxes
Income tax provision/(benefit)
Net income/(loss)
Other comprehensive income/(loss), net of tax:
Unrealized gain/(loss) on marketable securities
Foreign currency translation gain/(loss)
Total other comprehensive income/(loss), net of tax
Comprehensive income/(loss)
Earnings per share:
Basic (in USD per share)
Diluted (in USD per share)
Weighted average shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments